Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: proteolytic bacterial enzymes - Hansa Biopharam AB

Next Previous
Drug Profile

Research programme: proteolytic bacterial enzymes - Hansa Biopharam AB

Alternative Names: Endoglycosidase of Streptococcus pyogenes; EndoS; NiceR; Second generation IdeS; Second generation Ig-G-degrading enzyme of Streptococcus pyogenes

Latest Information Update: 28 Dec 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Hansa Medical AB
  • Developer Hansa Biopharma AB
  • Class Anti-inflammatories; Bacterial proteins; Enzymes; Immunotherapies
  • Mechanism of Action Immunoglobulin modulators; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Autoimmune disorders
  • Research Transplant rejection
  • Discontinued Rheumatoid arthritis; Streptococcal infections

Most Recent Events

  • 20 Dec 2018 Hansa Medical is now called Hansa Biopharma
  • 02 Feb 2018 Preclinical development in Autoimmune disorders is still underway in Sweden
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Autoimmune-disorders in Sweden (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top